GNOM
·NASDAQ
--
--(--)
--
--(--)
Key Stats
Assets Under Management
55.02MUSD
Fund Flows (1Y)
-23.37MUSD
Dividend Yield
0.07%
Discount/Premium to NAV
0.03%
Shares Outstanding
1.20M
Expense Ratio
0.50%
About Global X Genomics & Biotechnology ETF
Issuer
Global X Management Company LLC
Brand
Global X
Inception Date
Apr 5, 2019
Structure
Open-Ended Fund
Index Tracked
Solactive Genomics Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
Global X Management Co. LLC
Distributor
SEI Investments Distribution Co.
GNOM is Global X's take on biotech, with more of an emphasis on genomics specifically. The fund fleshes out its description of this sector by including companies that derive more than 50% of their revenues from the following five business activities: (i) gene editing, (ii) genomic sequencing, (iii) development and testing of genetic medicine/therapies, (iv) computational genomics and genetic diagnostics, and/or (v) biotechnology. The fund uses a proprietary natural language processing algorithm to identify and rank eligible firms based on public documents, such as filings and disclosures. Holdings may span the market-cap spectrum and come from across the globe, including some emerging markets. The market-cap-weighted index is reconstituted and rebalanced semi-annually.
Classification
Asset Class
Equity
Category
Sector
Focus
Theme
Niche
Genomic Advancements
Strategy
Vanilla
Geography
U.S.
Weighting Scheme
Market Cap
Selection Criteria
Market cap
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | +7.00% | +25.06% | +18.67% | +12.54% | -10.82% | -52.08% |
NAV Total Return | +7.54% | +27.47% | +20.74% | +11.23% | -11.33% | -49.82% |
Ratings
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
99.72%
Technology
0.28%
Healthcare
99.72%
Technology
0.28%
Asset
Region
92.13%
7.08%
0.8%
Category
Ratio
North America
92.13%
Europe
7.08%
Asia
0.80%
Investment Style
Mega
Large
Medium
Multi
Small
Value
Blend
Growth
Multi-Cap Growth
Comprises companies of multiple sizes that have high growth potential. These ETFs focus on firms across different market caps with promising growth prospects.
Top 10 Holdings
Symbol
Ratio
ARROWHEAD PHARMACEUTICALS IN
6.49%
ILLUMINA INC
5.29%
GUARDANT HEALTH INC
5.27%
PRAXIS PRECISION MEDICINES I
5.12%
NATERA INC
4.49%
MODERNA INC
4.45%
VERTEX PHARMACEUTICALS INC
4.04%
AVIDITY BIOSCIENCES INC
3.85%
BIOMARIN PHARMACEUTICAL INC
3.83%
QIAGEN N.V.
3.57%
Top 10 Weight 46.4%
52 Total Holdings
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2025-06-27 | 2025-06-27 | 2025-07-07 | 0.008 |
| 2022-12-29 | 2022-12-30 | 2023-01-09 | 0.016 |
| 2021-12-30 | 2021-12-31 | 2022-01-07 | 0.006 |
| 2020-12-30 | 2020-12-31 | 2021-01-08 | 0.032 |
Premium/Discount Chart
Premium/Discount to NAV
Price
1M
Assets Under Management
Assets Under Management
1M
Fund Flows
Inflows
Outflows
1M
